Qin, A.; Wu, C.-R.; Ho, M.-C.; Tsai, C.-Y.; Chen, P.-J.
Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. Int. J. Mol. Sci. 2024, 25, 433.
https://doi.org/10.3390/ijms25010433
AMA Style
Qin A, Wu C-R, Ho M-C, Tsai C-Y, Chen P-J.
Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. International Journal of Molecular Sciences. 2024; 25(1):433.
https://doi.org/10.3390/ijms25010433
Chicago/Turabian Style
Qin, Albert, Chang-Ru Wu, Ming-Chih Ho, Chan-Yen Tsai, and Pei-Jer Chen.
2024. "Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results" International Journal of Molecular Sciences 25, no. 1: 433.
https://doi.org/10.3390/ijms25010433
APA Style
Qin, A., Wu, C.-R., Ho, M.-C., Tsai, C.-Y., & Chen, P.-J.
(2024). Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. International Journal of Molecular Sciences, 25(1), 433.
https://doi.org/10.3390/ijms25010433
